Related Experiment Video
Updated: Nov 7, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Association between Homocysteine Levels and Psoriasis: A Meta-Analysis
Jung Eun Kim1, Ho Jung Lee1, Jong Suk Lee1
1Department of Dermatology, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Insights
Psoriasis patients have higher homocysteine (Hcy) levels, a marker of cardiovascular risk. This elevation is particularly significant in individuals with severe psoriasis (PASI >10).
Area of Science:
- Dermatology
- Cardiovascular Medicine
- Clinical Chemistry
Background:
- Psoriasis is a chronic inflammatory disease linked to increased cardiovascular disease risk.
- Elevated homocysteine (Hcy) levels are recognized biomarkers for cardiovascular risk.
- Previous studies on the association between psoriasis and Hcy levels have yielded inconclusive results.
Purpose of the Study:
- To conduct a systematic literature review and meta-analysis to clarify the relationship between psoriasis and homocysteine levels.
- To investigate whether psoriasis is associated with altered plasma homocysteine concentrations.
Main Methods:
- A comprehensive search of five major scientific databases (MEDLINE, Embase, Cochrane Library, Scopus, Web of Science) was performed.
- 16 studies directly measuring plasma homocysteine levels in psoriasis patients were identified from 307 publications.
- A meta-analysis was conducted on data from 2,091 subjects.
Main Results:
- Psoriasis patients exhibited significantly higher homocysteine levels compared to healthy controls (WMD, 3.30; 95% CI, 1.58–5.02).
- Subgroup analysis indicated that patients with higher Psoriasis Area and Severity Index (PASI) scores (PASI >10) showed significantly elevated homocysteine levels (WMD, 4.17; 95% CI, 1.18–7.16).
- Patients with lower PASI scores (PASI ≤10) did not demonstrate a significant difference in homocysteine levels compared to controls (WMD, 0.76; 95% CI, -1.84–3.35).
Conclusions:
- This meta-analysis confirms that psoriasis patients, especially those with severe disease (PASI >10), have significantly elevated homocysteine levels.
- The findings suggest a potential link between psoriasis severity and homocysteine levels.
- Further research is warranted to elucidate the precise association between homocysteine and psoriasis severity.
Background:
Psoriasis is a multifactorial disease associated with an increased risk for metabolic syndrome and cardiovascular diseases. Elevated levels of homocysteine (Hcy) are a marker of cardiovascular risk. Several studies have evaluated the associations between psoriasis and Hcy levels; however, the results remain inconclusive.
Objective:
We performed a systematic review of the literature and a meta-analysis to better understand the relationship between psoriasis and Hcy.
Methods:
Five scientific databases (MEDLINE, Embase, Cochrane Library, Scopus, and Web of Science) were searched to identify relevant studies. A review of 307 publications identified 16 studies that directly assessed plasma levels of Hcy in psoriasis patients.
Results:
A total of 16 studies including 2,091 subjects were included in the meta-analysis. Hcy levels were significantly higher in psoriasis patients relative to healthy controls (weighted mean difference [WMD], 3.30; 95% confidence interval [CI], 1.58∼5.02; I 2=82.1%). Subgroup analyses revealed that patients with higher mean psoriasis area severity index (PASI) scores (PASI>10) had significantly higher Hcy levels compared to healthy controls (WMD, 4.17; 95% CI, 1.18∼7.16; I 2=88.3%), whereas patients with lower mean PASI scores (PASI ≤10) had not (WMD, 0.76; 95% CI, -1.84∼3.35; I 2=72.2%).
Conclusion:
This meta-analysis found that psoriasis patients, in particular those with PASI >10, had significantly higher Hcy levels compared to healthy controls. Further research is needed to determine the association between Hcy levels and psoriasis severity.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Psychological and Sociocultural Causes of Schizophrenia
